Omrix Biopharmaceuticals, Inc.·4

Jun 19, 4:45 PM ET

Burshtine Michael 4

4 · Omrix Biopharmaceuticals, Inc. · Filed Jun 19, 2007

Insider Transaction Report

Form 4
Period: 2007-06-18
Burshtine Michael
Senior VP and CFO
Transactions
  • Purchase

    Put Options (right to sell)

    2007-06-18$2.98/sh+1,000$2,9851,000 total
    Exercise: $30.00From: 2007-06-18Exp: 2008-01-19Common Stock, par value $0.01 per share (100,000 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION